NT5C2 Gene SPG45 Genetic Test sale cost 4400 AED
KCNQ3 Gene Seizures Benign Neonatal Type 2 Genetic Test sale cost 4400 AED KCNQ3 Gene Seizures Benign Neonatal Type 2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
VPS37A Gene SPG53 Genetic Test sale cost 4400 AED VPS37A Gene SPG53 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

NT5C2 Gene SPG45 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NT5C2 Gene SPG45 Genetic Test is a specialized diagnostic tool designed to identify mutations in the NT5C2 gene, which are associated with Spastic Paraplegia 45 (SPG45), a rare form of hereditary spastic paraplegia. This condition is characterized by progressive stiffness and contraction in the lower limbs, leading to mobility challenges and other neurological symptoms. By analyzing the patient’s DNA, this test can confirm the presence of genetic alterations in the NT5C2 gene, providing crucial information for accurate diagnosis, management, and genetic counseling of affected individuals and their families.

The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics that employs cutting-edge technology and methodologies to ensure high accuracy and reliability of results. The cost of the NT5C2 Gene SPG45 Genetic Test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive insights it offers into the patient’s genetic makeup. This information is invaluable for devising personalized treatment plans and understanding the inheritance patterns, potentially benefiting other family members.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NT5C2 Gene SPG45 Genetic Test

At DNA Labs UAE, we offer the NT5C2 Gene SPG45 Genetic Test for individuals who may be affected by hereditary spastic paraplegia type 45 (SPG45), a neurological disorder characterized by stiffness and weakness in the legs.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the NT5C2 Gene SPG45 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by NT5C2 Gene SPG45.

Test Details

The NT5C2 gene is associated with hereditary spastic paraplegia type 45 (SPG45), a neurological disorder. This condition is characterized by progressive stiffness and weakness in the legs, which can result in difficulty walking and other motor impairments.

The NT5C2 Gene SPG45 Genetic Test utilizes Next-Generation Sequencing (NGS) technology to analyze an individual’s DNA sequence. This allows for the identification of specific genetic variations or mutations that may be linked to SPG45 or other disorders.

In the case of SPG45, the NGS genetic test analyzes the NT5C2 gene for any mutations or variations that may be responsible for the development of hereditary spastic paraplegia. This test can confirm a diagnosis and provide information about the specific genetic cause of the disorder.

To perform the NT5C2 Gene SPG45 Genetic Test, a DNA sample is required. This sample can be obtained through a blood sample or cheek swab. The DNA is then sequenced using advanced technologies to identify any variations or mutations in the NT5C2 gene.

The results of the NGS genetic test can provide valuable information for individuals and their healthcare providers. This includes confirming a diagnosis, understanding the inheritance pattern of the disorder, and potentially guiding treatment decisions or management strategies.

Test Name NT5C2 Gene SPG45 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NT5C2 Gene SPG45 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with NT5C2 Gene SPG45
Test Details

The NT5C2 gene is associated with a neurological disorder called hereditary spastic paraplegia type 45 (SPG45). This disorder is characterized by progressive stiffness and weakness in the legs (spastic paraplegia), which can lead to difficulty walking and other motor impairments.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. It allows for the identification of specific genetic variations or mutations that may be associated with a particular disorder or condition.

In the context of SPG45, NGS genetic testing can be used to analyze the NT5C2 gene for any mutations or variations that may be responsible for the development of hereditary spastic paraplegia. This can help in confirming a diagnosis and providing information about the specific genetic cause of the disorder.

NGS genetic testing for the NT5C2 gene in SPG45 can be performed using a DNA sample, typically obtained through a blood sample or cheek swab. The DNA is then sequenced using advanced technologies to identify any variations or mutations in the NT5C2 gene.

The results of the NGS genetic test can provide valuable information for individuals and their healthcare providers, including confirming a diagnosis, understanding the inheritance pattern of the disorder, and potentially guiding treatment decisions or management strategies.

SKU: TEST-2010 Category:

Related products